Company intelligence / Profile preview

Ekso Bionics Holdings

San Rafael, California, United States

Ownership: Private
Employees: ~80
Development stage: Other

Overview

Ekso Bionics’ exoskeletons, notably EksoNR and Ekso Indego, are FDA-cleared for rehabilitation in stroke, SCI, ABI, and MS and have enabled thousands of individuals to regain mobility; the company’s systems are commercially available for hospital and home use[2][4][5][8][10].

Therapeutic areas: Neurology
Modalities: DeviceWearable robotic exoskeleton
Industry: Assistive Medical Devices

Partnerships

Lockheed Martin (military development, HULC exoskeleton)[6][8]NVIDIA (Connect AI program, foundation model for human motion)[5]Parker Hannifin (acquired Human Motion & Control business unit, Indego exoskeleton)[8][10]Ford, Boeing (EksoVest industrial exoskeleton for workplace injury prevention)[6]

Beyond the preview

Go deeper on Ekso Bionics Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ekso Bionics Holdings.

Explore the full profile